| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.25 | 0.2 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |